Justine’s focus in on integrating psycho-spiritual care, including psychedelic therapies, into oncology and palliative care settings to help reduce existential and spiritual distress and improve quality of life.

Every person deserves to meet the end of their life with dignity, clarity, and peace - yet for many Australians, this is not the reality. For instance, the literature tells us that around 51% of cancer patients will experience existential distress. This isn't just a statistic, it’s a mirror held up to a widespread, unmet need in our healthcare system.

As the co-founder of End Wise, a not-for-profit organisation, she leads efforts to transform end-of-life care through the safe and legal use of psychedelic-assisted therapy.

At End Wise, we believe everyone facing the end of life deserves access to holistic, compassionate, and transformative care.

End Wise is committed to advancing psychedelic-assisted therapy within palliative care by fostering education, research, policy engagement, and collaboration. Our advocacy is grounded in a deep understanding of the therapeutic potential of psychedelics to alleviate suffering and enhance quality of life for patients and their caregivers.

Through normalising the therapeutic use of psychedelics, End Wise empowers clinicians, patients, and families with informed choices towards end of life—helping to reshape the landscape of compassionate care.